Iowa Admin. Code r. 657-8.22

Current through Register Vol. 47, No. 6, September 18, 2024
Rule 657-8.22 - Notification of interchangeable biological product selection

Pursuant to Iowa Code section 155A.32, when a pharmacist substitutes a biological product that is an interchangeable biological product for the biological product prescribed, the pharmacist or pharmacist's designee shall, within five business days of dispensing the biological product, communicate to the prescriber the name and manufacturer of the biological product dispensed unless the prescription information has been entered into an electronic record system, such as an electronic medical record, electronic prescribing system, pharmacy benefit management system, or a pharmacy record to which the prescriber has access. The manner of communication to the prescriber may be via telephone, facsimile, electronic transmission, or other prevailing means.

This rule is intended to implement Iowa Code section 155A.32.

Iowa Admin. Code r. 657-8.22

Amended by IAB June 20, 2018/Volume XL, Number 26, effective 7/25/2018